We at Oaknet are dedicated towards building customer centric product range. We have over 3 decades legacy in Dermatology & Gynaecology. We have heritage brands like Cosvate & Flucos in Dermatology and Jectocos & Ferose in Gynaecology. Our major focus therapy areas are Cardiology, Diabetology, Orthopedics and other therapy areas.
We have identified exports a distinct growth driver for our present and long term growth objectives.
Our present export business is focused towards some prominently emerging markets like Sri lanka, Myanmar, Cambodia, Kenya, Tanzania, Mauritius and Jamaica.
We are committed towards providing global community with novel pharmaceutical products at the most affordable cost. Currently we are experiencing a great business growth in international markets of Asia and Africa, we are planning to take this success ahead in other emerging and regulated markets of the world.
To support these growth plans we are actively seeking alliances in Middle Est and Central Asia, South and Central America and The European Union.
At Oaknet, we are committed towards knowledge enhancement of doctors. Our aim is to provide products with novel concepts and strong scientific backup. In the era of digitalization we are engaging our doctors through various digital platforms. We have conducted Webinars with the help of International Doctors which are associated with renowned Medical Universities & Organizations.
Recently we have conducted 2 Webinars on Azilsartan by Prof. George Bakris & Prof. William B White, who were a part of Clinical Trials conducted on Azilsartan and another webinar on novel concept of Myo-inositol with D-Chiroinositol by Dr. Nicholas Mendoza Elected President of Spanish Menopause Society & Dr. Monica Olivares Martin Research Director of Biosearch Life Spain.